Advertisement
Screener

CapsoVision, Inc (CV) Total Liabilities and Equity

2.8 / 5 stars · 68/120 Roast Me

CapsoVision, Inc Total Liabilities and Equity

CapsoVision, Inc (CV) had Total Liabilities and Equity of $18.57 million as of 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Balance Sheet

us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-13

  • 2026-06-30: Liabilities and Equity $18.57M.
  • 2026-03-31: Liabilities and Equity $25.95M.
  • 2025-12-31: Liabilities and Equity $18.16M.
  • 2025-09-30: Liabilities and Equity $25.66M.
Period endLiabilities and Equity
2026-06-30$18.57M
10-Q · filed 2026-08-13
2026-03-31$25.95M
10-Q · filed 2026-05-14
2025-12-31$18.16M
10-Q · filed 2026-08-13
2025-09-30$25.66M
10-Q · filed 2025-11-13
2025-06-30$9.55M
10-Q · filed 2025-08-14
2024-12-31$16.80M
10-K · filed 2026-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Vivani Medical, Inc. (VANI)United States$0.111B
electroCore, Inc. (ECOR)United States$0.102B
Neuraxis, INC (NRXS)United States$0.097B
Nexalin Technology, Inc. (NXL)United States$0.094B
Streamex Corp. (STEX)United States$0.089B-0.19
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B